Appraisal Arbitrage May Be A Hedge Fund Strategy
A recent Delaware case involving the acquisition of Transkaryotic Therapies Inc. by Shire Pharmaceuticals Group plc has the potential to revolutionize the use of appraisal rights in cash mergers involving Delaware...To view the full article, register now.
Already a subscriber? Click here to view full article